Experienced in Non-Langerhans-Cell Histiocytosis

Dr. Philip A. Roehrs

Pediatric Hematology Oncology
100 Medical Park Dr, Ste 310, 
Concord, NC 
Offers Telehealth
Experienced in Non-Langerhans-Cell Histiocytosis
100 Medical Park Dr, Ste 310, 
Concord, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Philip Roehrs is a Pediatric Hematologist Oncology provider in Concord, North Carolina. Dr. Roehrs is rated as an Experienced provider by MediFind in the treatment of Non-Langerhans-Cell Histiocytosis. His top areas of expertise are Hemophagocytic Lymphohistiocytosis, Juvenile Myelomonocytic Leukemia (JMML), Non-Langerhans-Cell Histiocytosis, and Histiocytosis.

His clinical research consists of co-authoring 15 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles and participated in 1 clinical trial in the study of Non-Langerhans-Cell Histiocytosis.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in NC
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthKeepers
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Piedmont
  • HMO
  • POS
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

100 Medical Park Dr, Ste 310, Concord, NC 28025
Other Locations
1001 Blythe Blvd, Medical Center Plaza Ste 601, Charlotte, NC 28203
1215 Lee St, Charlottesville, VA 22908

Additional Areas of Focus

Dr. Roehrs has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Administration of Autologous CAR-T Cells Targeting the CD19 Antigen and Containing the Inducible caspase9 Safety Switch in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Administration of Autologous CAR-T Cells Targeting the CD19 Antigen and Containing the Inducible caspase9 Safety Switch in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Drug, Biological
Study Drugs: Rimiducid, Cyclophosphamide, Fludarabine, CD19-Positive/iC9 CAR-T Cells
Study Phase: Phase 1/Phase 2
A Phase 2/3 Open-label Single Arm Multicentre Study to Assess Safety Tolerability Pharmacokinetics and Efficacy of i.v. Administrations of NI-0501 an Anti-IFNγ mAb in Paediatric Patients With Primary Haemophagocytic Lymphohistiocytosis
A Phase 2/3 Open-label Single Arm Multicentre Study to Assess Safety Tolerability Pharmacokinetics and Efficacy of i.v. Administrations of NI-0501 an Anti-IFNγ mAb in Paediatric Patients With Primary Haemophagocytic Lymphohistiocytosis
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

15 Total Publications

Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH).
Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH).
Journal: Orphanet journal of rare diseases
Published: May 24, 2024
Similar Doctors
Ashley Hinson
Advanced in Non-Langerhans-Cell Histiocytosis
Dr. Ashley Hinson
Pediatric Hematology Oncology
Advanced in Non-Langerhans-Cell Histiocytosis
Dr. Ashley Hinson
Pediatric Hematology Oncology

Atrium Health Levine Children’s Cancer & Blood Disorders, A Facility Of Carolinas Medical Center

1001 Blythe Blvd., Suite 3000, 
Charlotte, NC 
 (21.0 miles away)
704-381-9900
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ashley Hinson is a Pediatric Hematologist Oncology provider in Charlotte, North Carolina. Dr. Hinson is rated as an Experienced provider by MediFind in the treatment of Non-Langerhans-Cell Histiocytosis. Her top areas of expertise are Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Histiocytosis, and Reticulohistiocytoma.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Roehrs's expertise for a condition
ConditionClose
        View All 7 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile